OZEM vs PPH
Roundhill GLP-1 & Weight Loss ETF against VanEck Pharmaceutical ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
23%
3 shared positions
Fee gap
23 bp
PPH is cheaper
1-year return gap
16.9 pts
PPH is ahead
Larger fund
PPH
$1.0B
Side by side
| OZEM | PPH | |
|---|---|---|
| Fund | Roundhill GLP-1 & Weight Loss ETF | VanEck Pharmaceutical ETF |
| Issuer | Roundhill | VanEck |
| Category | Biotech & Health Innovation | Health Care |
| Expense ratio | 0.59% | 0.36% |
| Assets | $55M | $1.0B |
| Average daily dollar volume | $493K | $32M |
| Listed | May 20, 2024 | Dec 20, 2011 |
| FrenzyCap score | 33 | 62 |
| 1-month return | −5.9% | +0.8% |
| 3-month return | −9.6% | +1.6% |
| Year to date | −13.3% | +7.1% |
| 1-year return | +1.4% | +18.3% |
| 30-day volatility | 20.4% | 16.1% |
| Worst drawdown, 1 year | −20.9% | −11.5% |
| Trailing 12-month yield | 1.39% | 1.94% |
| Holdings | 26 | 27 |
| Top 10 weight | 65.9% | 71.5% |
| Look-through P/E | — | 39.0 |
| Holdings vs fair value | +3.2% | +5.2% |
| Holdings above 200-day average | 54% | 67% |
| Net flow, latest 3 reported months | +$286K thru Jun 2026 | −$449M thru Jun 2026 |
| 30-day implied volatility | 36.5% | 20.7% |
| Holdings as of | as of Jun 30, 2026SEC filing | as of Oct 8, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
32% of OZEM · 32% of PPH
Sector mix of the stock holdings
| Sector | OZEM | PPH | Gap |
|---|---|---|---|
| Health Care | 57.2% | 96.1% | −38.9% |
| Consumer Staples | 0.0% | 3.8% | −3.8% |
More: full overlap table · OZEM holdings · PPH holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.